Laparascopic Sleeve Gastrectomy vs. Endoscopic Gastric Plication in Obesity (SLAVIA)
Primary Purpose
Obesity
Status
Not yet recruiting
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
laparoscopic sleeve gastrectomy
conservative treatment of obesity
endoscopic gastric plication
Sponsored by
About this trial
This is an interventional treatment trial for Obesity focused on measuring Obesity, Diabetes mellitus, Endoscopy, Surgery, Gut microbiota
Eligibility Criteria
Inclusion Criteria:
- BMI > 35 kg/m2
- For patients with type 2 diabetes - stable antidiabetic medication > 1 month
- Age 18-60 years
Exclusion Criteria:
- Other diabetes mellitus types (type 1 DM, monogenic DM, secondary DM)
- Prior gastrointestinal (GIT) surgery interfering with study procedure
- Severe gastroesophageal reflux, severe GIT motility disorder
- Active malignancy
- Acute myocardial infarction, unstable angina pectoris, acute stroke 3 months prior to enrolment
- Acute liver or kidney failure
- Transplantation of insulin producing tissue
- Gravidity or lactation
- Mental disorder
- Inability to sign informed consent
- Any other contraindication of bariatric surgery or bariatric endoscopy procedure
6. Acute liver or kidney failure 7. Transplantation of insulin producing tissue 8. Gravidity or lactation 9. Mental disorder 10. Inability to sign informed consent 11. Any other contraindication of bariatric surgery or bariatric endoscopy procedure
Sites / Locations
- Institute for Clinical and Experimental Medicine
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
Conservative treatment group
Laparoscopic sleeve gastrectomy
endoscopic gastric plication
Arm Description
Obese patients treated with conservative approach - diet.
Obese patients treated with laparoscopic sleeve gastrectomy.
Obese patients treated with endoscopic gastric plication.
Outcomes
Primary Outcome Measures
Change in Body Weight
To compare the change in body weight after laparoscopic sleeve gastrectomy ve. endoscopic gastric plication and endoscopic gastric plication vs. conservative treatment of obesity
Secondary Outcome Measures
Change in Glycated Hemoglobin
To compare the change in glycated hemoglobin after laparoscopic sleeve gastrectomy ve. endoscopic gastric plication and endoscopic gastric plication vs. conservative treatment of obesity
Change in serum glucagon-like peptide 1 (GLP-1)
To compare the change in serum glucagon-like peptide 1 (GLP-1) after laparoscopic sleeve gastrectomy ve. endoscopic gastric plication and endoscopic gastric plication vs. conservative treatment of obesity
Change in fasting blood glucose
To compare the change in fasting blood glucose after laparoscopic sleeve gastrectomy ve. endoscopic gastric plication and endoscopic gastric plication vs. conservative treatment of obesity
Full Information
NCT ID
NCT05259644
First Posted
January 11, 2022
Last Updated
February 17, 2022
Sponsor
Institute for Clinical and Experimental Medicine
1. Study Identification
Unique Protocol Identification Number
NCT05259644
Brief Title
Laparascopic Sleeve Gastrectomy vs. Endoscopic Gastric Plication in Obesity
Acronym
SLAVIA
Official Title
The Influence of Laparascopic SLeeve gAstrectomy Vs. Endoscopic Gastric Plication on Body weIght, Metabolic pArameters and Microbiota Composition in Patients With Obesity: Randomized, Open-labelled Study (SLAVIA Trial)
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
February 2022 (Anticipated)
Primary Completion Date
May 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institute for Clinical and Experimental Medicine
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The project will describe the efficacy and safety of laparoscopic sleeve gastrectomy and endoscopic gastric plication procedures as compared to conservative therapy and clarify the mechanisms of action of these treatments. The project will also contribute to more precise indications of bariatric or endoscopic methods in clinical practice and enable personalized choice of therapy for particular patient.
Detailed Description
Bariatric surgery is the most efficacious treatment of obesity and type 2 diabetes mellitus. Novel endoscopic methods based on the principles of bariatric surgery are also highly effective. No direct randomized comparison of both types of treatment has been performed to date and the mechanisms of action of both procedures are still only partially clarified. The aim of the project is to perform a randomized trial comparing efficacy and safety of three treatment options in patients with obesity: laparoscopic sleeve gastrectomy, endoscopic gastric plication and conservative treatment. A further aim is to characterize the influence of the three treatments on subclinical inflammation, gut microbiota composition and changes of gastrointestinal hormones. The results of the project will describe the efficacy and safety of these procedures as compared to conservative therapy and clarify the mechanisms of action of these treatments. The project will also contribute to more precise indications of bariatric or endoscopic methods in clinical practice and enable personalized choice of therapy for particular patient.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Obesity, Diabetes mellitus, Endoscopy, Surgery, Gut microbiota
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
In total 75 patients will be randomized into 3 groups.
Masking
Investigator
Allocation
Randomized
Enrollment
75 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Conservative treatment group
Arm Type
Active Comparator
Arm Description
Obese patients treated with conservative approach - diet.
Arm Title
Laparoscopic sleeve gastrectomy
Arm Type
Active Comparator
Arm Description
Obese patients treated with laparoscopic sleeve gastrectomy.
Arm Title
endoscopic gastric plication
Arm Type
Active Comparator
Arm Description
Obese patients treated with endoscopic gastric plication.
Intervention Type
Device
Intervention Name(s)
laparoscopic sleeve gastrectomy
Intervention Description
Surgical procedure - laparoscopic sleeve gastrectomy.
Intervention Type
Other
Intervention Name(s)
conservative treatment of obesity
Intervention Description
Diet and exercise
Intervention Type
Device
Intervention Name(s)
endoscopic gastric plication
Intervention Description
Endoscopic procedure - endoscopic gastric plication
Primary Outcome Measure Information:
Title
Change in Body Weight
Description
To compare the change in body weight after laparoscopic sleeve gastrectomy ve. endoscopic gastric plication and endoscopic gastric plication vs. conservative treatment of obesity
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change in Glycated Hemoglobin
Description
To compare the change in glycated hemoglobin after laparoscopic sleeve gastrectomy ve. endoscopic gastric plication and endoscopic gastric plication vs. conservative treatment of obesity
Time Frame
6 months
Title
Change in serum glucagon-like peptide 1 (GLP-1)
Description
To compare the change in serum glucagon-like peptide 1 (GLP-1) after laparoscopic sleeve gastrectomy ve. endoscopic gastric plication and endoscopic gastric plication vs. conservative treatment of obesity
Time Frame
6 months
Title
Change in fasting blood glucose
Description
To compare the change in fasting blood glucose after laparoscopic sleeve gastrectomy ve. endoscopic gastric plication and endoscopic gastric plication vs. conservative treatment of obesity
Time Frame
6 months
Other Pre-specified Outcome Measures:
Title
Change in hsCRP
Description
To compare the change in high sensitive C reactive protein as a marker of low grade inflammation after laparoscopic sleeve gastrectomy and endoscopic gastric plication vs. conservative treatment of obesity
Time Frame
6 months
Title
Rehospitalizations
Description
To compare the rate of rehospitalizations after laparoscopic sleeve gastrectomy and endoscopic gastric plication vs. conservative treatment of obesity
Time Frame
6 months
Title
Change in the IWQOL (The Impact of Weight on Quality of Life) questionnaire
Description
To compare the change in quality of life as assessed by the IWQOL (The Impact of Weight on Quality of Life) questionnaire after laparoscopic sleeve gastrectomy and endoscopic gastric plication vs. conservative treatment of obesity
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
BMI > 35 kg/m2
For patients with type 2 diabetes - stable antidiabetic medication > 1 month
Age 18-60 years
Exclusion Criteria:
Other diabetes mellitus types (type 1 DM, monogenic DM, secondary DM)
Prior gastrointestinal (GIT) surgery interfering with study procedure
Severe gastroesophageal reflux, severe GIT motility disorder
Active malignancy
Acute myocardial infarction, unstable angina pectoris, acute stroke 3 months prior to enrolment
Acute liver or kidney failure
Transplantation of insulin producing tissue
Gravidity or lactation
Mental disorder
Inability to sign informed consent
Any other contraindication of bariatric surgery or bariatric endoscopy procedure
6. Acute liver or kidney failure 7. Transplantation of insulin producing tissue 8. Gravidity or lactation 9. Mental disorder 10. Inability to sign informed consent 11. Any other contraindication of bariatric surgery or bariatric endoscopy procedure
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jan Kral, MD
Phone
+420236053280
Email
jan.kral@ikem.cz
First Name & Middle Initial & Last Name or Official Title & Degree
Even Machytka, MD
Phone
+420236053280
Email
even.machytka@ikem.cz
Facility Information:
Facility Name
Institute for Clinical and Experimental Medicine
City
Prague
ZIP/Postal Code
14021
Country
Czechia
12. IPD Sharing Statement
Learn more about this trial
Laparascopic Sleeve Gastrectomy vs. Endoscopic Gastric Plication in Obesity
We'll reach out to this number within 24 hrs